Senior Fellow and Principal InvestigatorA*STAR Infectious Diseases Labs (ID Labs)
Laurent Rénia obtained his PhD in 1991 from University Pierre et Marie Curie (now Sorbonne University) in Paris, France and did his post-doctoral New York University (1991-1992). He then returned to Paris in 1993 where he obtained a permanent position as junior research scientist at the French National Institute of Health (INSERM) in the INSERM Unit 313 at the Hopital Pitie-Salpetriere in Paris. He moved to the INSERM Unit 445 at the Institut Cochin in Paris where he started his own group in 1997. In 2001-2006, he was the Research Director at INSERM, and Co-director and Director of the Department of Immunology at the Institut Cochin. He joined SIgN in 2007, where he was Executive Director from 2013 to 2020 before becoming the founding Executive Director of the A*STAR ID Labs from 2020 to 2021. He is now Professor of infectious Diseases and director of the respiratory and Infectious Diseases Program in Lee Kong Chian School of Medicine, Nanyang Technological University, as well as a Professor in the School of Biological Sciences at NTU and a Senior Fellow and Principal Investigator at A*STAR ID Labs. He also holds an adjunct position in the French National Institute of Health (INSERM). He has published more than 330 articles and book chapters and is an Academic Editor for Infection and Immunity, PLoS ONE, Infection and Immunity, Microbial Pathogenesis, Microbial cell and Frontiers in Immunology.
While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals,
A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the
A novel tissue-profiling approach provides new insights into the mechanisms of fatal COVID-19 by analysing
Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to
An analysis of cellular immune responses reveals that mixing COVID-19 vaccines and boosters may offer